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Summary: Heart rate and plasma Catecholamines were determined in 16 patients with alcoholic fatty liver
and 14 patients with alcoholic cirrhosis of the liver. The measurements were performed at rest and after
exercise on the bicycle ergometer, on average 11 days after admission to hospital. In comparison with a
control group, the mean heart rate of the patient group was significantly increased at rest and under
graduated loading. Significantly increased plasma catecholamine concentrations under resting conditions
were observed in both groups of patients, the increase being more pronounced in the cirrhotics (increased
with progressive liver damage, significant differences being found between the control group and each of the
two groups of patients). During exercise under a load of 50 or 100 watts, the increases in adrenaline,
noradrenaline and döpamine concentrations were greatest in patients with alcoholic cirrhosis. With reference
to the initial values, however* the increases in concentration were identical in all three groups.
In the patients, metabolisin of the Catecholamines remained ünchanged after an average of 11 days abstinence
from alcohol; they showed a significantly diminished elimination of vanillylmandelic acid in the urine and,
compared with the greatly elevated plasma catecholamine levels, they showed only a moderate increase in the
excretion of Catecholamines. The results reported here support the assumption that changes in catecholamine
metabolism compatible with an increased sympathetic activity are present in chronic alcoholics without
advanced liver damage.
Plasma- und Urinkatecholamine in Ruhe und unter Belastung bei Patienten mit alkoholischer Leberschädigung
Zusammenfassung: Bei 16 Patienten mit alkoholischer Fettleber und 14 Patienten mit Alkoholcirrhose wurden
im Mittel 11 Tage nach Klinikaufnahme die Herzfrequenz und die Plasmakatecholamine in Ruhe und nach
Fahrradergometrie bestimmt. Im Vergleich zu einer Kontrollgruppe war die mittlere Herzfrequenz bei
beiden Patientenkollektiven in Ruhe und unter dosierter Belastung signifikant erhöht. Signifikant erhöhte
Katecholaminkonzentrationen im Plasma unter Ruhebedingungen wurden in beiden Patientengruppen beob-
!) This study was supported by the Robert Bosch foundation, Stuttgart (F.R.G.).
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achtel, wobei der Anstieg bei den Cirrhotikern am ausgeprägtesten war. Während der Belastung mit 50 und
100 Watt waren die Anstiege der Adrenalin-, Noradrenalin- und Dopaminkonzentrationen bei den Patienten
mit Alkoholcirrhose am höchsten. Auf die Ausgangswerte bezogen waren die Konzentrationserhöhungen in
allen drei Kollektiven allerdings identisch.
Die Metabolisierung der Katecholamine ist bei den Patienten nach durchschnittlicher Alkoholabstinenz
von 11 Tagen weiterhin verändert. So wurde eine gegenüber der Kontrollgruppe sigpifikant verminderte
Ausscheidung der Vanillinmandelsäure und eine im Vergleich zu den stark erhöhten Katecholaminkonzentra-
tionen im Plasma nur mäßig erhöhte Katecholaminausscheidung nachgewiesen. Unsere Ergebnisse bestätigen
die Annahme, daß Änderungen des Katecholaminstoffwechsels — im Einklang mit einer erhöhten Sympathi-
cusaktivität — schon bei chronischen Alkoholikern ohne fortgeschrittenen Leberschaden auftreten.
Introduction
Alcohol ingestion, whether acute or chronic, brings
a change in the function of most endocrine organs in
humans (1). Data in the literature on the influence
of alcohol on catecholamine metabolism are in-
consistent. Following the acute administration of
high doses of alcohol, unchanged (2) and elevated (3)
quantities of adrenaline and noradrenaline have been
reported in the urine. Chronic alcohol consumption
has been reported to stimulate the sympathetic ner-
vous System leading to elevated plasma catecholamine
concentrations and raised excretion of cat-
echolamines in the urine (4, 5). However, in alcoholics
who remained abstinent for more than l week, no
differences were seen in the catecholamine excretion
in 24-hour urine vis-a-vis control subjects not drink-
ing alcohol (2).
The aim of the present study was to determine the
behaviour of the plasma concentration of the cat-
echolamines under resting conditions and under
graduated loading in a large random sample of
chronic alcoholics in the early phase after abstinence.
To clarify the question äs to whether the degree of
liver damage is of importance for possible changes in
function of the adrenal System, the investigations
were carried out in one group of patients with al-
coholic fatty liver and another with liver cirrhosis.
With a view to detecting possible changes in cat-
echolamine metabolism, the excretion of the cat-
echolamines and vanillylmandelic acid in 24-hour
urine was also measured.
Method and Material
Patients
Thirty patients with chronic alcohol abuse were studied. In 16
of these patients (14 men and 2 women), a fatty liver had been
verified histologically. In addition to fatty liver, three patients
also had signs of the beginning right heart failure, while two
öther patients had duodenal ulcers. The remaining 14 patients
(12 men and 2 women) had cirrhosis of the liver, the diagnosis
of this group of patients being based on Histologie fmdings
and/or (mainly) on typical clinical and biocheinicäl fmdings.
All these patients had oesophageal varices, and six patients
also had ascites. Five patients were treated with digoxin and
diuretics, while three patients received antacids and H2-receptor
antagonists. All the patients were admitted to hospital at least
4 days prior to the Start of the study. At the time of the
investigations, there was no evidence of withdrawal Symptoms.
In the last weeks prior to the study none of the patients showed
any Symptoms of gastrointestinal bleeding or clinically manifest
signs of chronic hepatic encephalopathy. All patients received
vitamins. At least 4 days prior to the Start of the investigations,
no changes were made in medication.
Table l presents a synopsis of the age distribution and char-
acteristic biochemical data of the patients on admission to
hospital, and of the control grojup. For this purpose, 16 healthy
volunteers (13 men and 3 women)"with an alcohol consumption
of less than 30 g per day were examined. Bicycle ergometry was
carried out in each case in the aftefnoon aftef a period of at
least two hours without food, the patients with fatty liver being
subjected to loading between the 4th and 30th day (mean 11
± 8 days), and the patients with liver cirrhosis between the 4th
and 38th day (mean 11 ± 9 days) after admission to hospital.
Bicycle ergometry
Ten minutes before initiating loading a catheter was piaced in
a vein of the forearm, and before starting seated ergometry a
sample of blood was drawn. Loading was eflfected on the bicycle
ergometer, the load being increased by 25 watts at intervals of
Tab. l. Distribution of age and characteristic clinical chemical parameters ( ± s) of the studied subjects.
Diagnosis
Fatty liver
Cirrhosis
Control group
n
16
14
16
Age
(years)
44 ± 7
43 ± 8
44 ± 8
-Glutamyl-
transferase
(U/l)
138 + 146
212 + 288
18 ± 10
Aspartate
amino-
transferase
(U/l)
41 ± 48
50 + 47
° 1 3 + 4
Alanine
amino-
transferase
(U/l)
42 ± 60
26 + 20
16 + 8
Prothrombin
time
(% öf ,·
normal)
95 ± 10
67 ± 19
100
Serum
electrö-
phoiresis
-globulin
fraction
0.188 ± 0.06
0.323 ± 0.10
0.123 ± 0.02
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one minute, up to a maximum load of 100 watts. Blood was
also drawn after 50 and 100 watts loading, and also in the lOth
minute of the recovery phase, with the patient seated. The heart
rate was determined from a continuously recorded ECG.
The plasma catecholamine concentrations were determined
with the aid of a radioenzymatic single isotope derivative tech-
nique (6), the intra-assay Variation coefficients for the de-
termination of dopamine, adrenaline and noradrenaline lying
between 5% and 8%.
On the day after ergometry, 24-hour urine specimens were
collected in plastic vessels containing 10 ml 6 mol/1 HCi. Ali-
quots were stored at —25 °C until analysed. The cat-
echolamines in the urine were also determined by the
radioenzymatic method (6), and the elimination of van-
illylmandelic acid using the method described by Pisano (7). In
order to compensate for any errors due to incomplete collection
of 24-hour urine, the catecholamine and vanillylmandelic acid
excretion was referred to the creatinine elimination. Creatinine
was determined using a modified Jaffa reaction (8).
The statistical significance of the results of bicycle ergometry
was tested with the aid of the t-test for independent samples.
Significance calculations for catecholamine and van-
illylmandelic acid excretions were carried out using the
Wilcoxon test.
Results
At rest there are highly significant differences between
the control group and the two groups of patients,
with respect to adrenaline, noradrenaline, dopamine
and heart rate (tab. 2). The mean concentration of
adrenaline and noradrenaline in the plasma is greater
in patients with alcoholic cirrhosis than in patients
with fatty liver.
During ergometry, these differences in the cat-
echolamine concentrations and the heart rate per-
sisted (tab. 2). At a load of 50 watts, of all the para-
meters measured, only the heart rates of all three
groups differ significantly from those at rest (in each
case p < 0.0001). With the exception of the dopamine
and adrenaline concentrations, at 100 watts, all the
Parameters measured differ significantly from their
initial values. In the lOth minute of the recovery
phase, neither the catecholamine concentrations nor
the heart rates can be differentiated statistically from
the initial levels. However, at this time, the mean
noradrenaline concentrations of both patient groups,
äs well äs the mean concentration of adrenaline in
the patients with alcoholic cirrhosis, show a tendency
to be higher than the respective basal concentrations,
even after the elapse of a period equivalent to 5 half-
lives.
At a load of 100 watts, the heart rate of the control
group is identical with that of both groups of patients
at 50 watts. At the same time, there is no difference
between the mean adrenaline and noradrenaline con-
centrations of the control subjects and the patients
with fatty liver. Even at rest, patients with alcoholic
cirrhosis have significantly higher noradrenaline, ad-
renaline and dopamine concentrations (p < 0.01, in
each case) than normal subjects under a load of 100
watts. Figure l shows the distribution of the absolute
figures for adrenaline, noradrenaline, dopamine and
heart rate referred to the respective resting figure,
Tab. 2. Inflüence of physical exercise on the plasma concentrations of catecholamines and heart rate of 16 control subjects, 16
patients with fatty liver and 14 patients with alcoholic liver cirrhosis (mean and Standard deviation).
Adrenaline Noradrenaline Dopamine Heart rate
(nmol/1) (nmol/1) (nmol/1) (min-1)
Con- Fatty Cirrhosis Con- Fatty Cirrhosis Con- Fatty Cirrhosis Con- Fatty Cirrhosis
trol liver trol liver trol liver trol liver
sub- sub- sub- sub-
jects jects jects jects
Before physical
exercise
50-watts
100 watts
10lh min of
recovery phase
X
s
pl
P2
X
s
X
s
pi
P2
X
s
0.53
0.15
0.50
0.15
0.69
0.26
0.44
0.14
0.86
0.38
+ +
0.85
0.34
1.20
0.53
+ +
0.84
0.31
1.09
0.30
+ + +
+
1.24*
0.50
1.85
0.78
+ + +
+ +
1.32
0.55
1.94
0.62
2.01
0.59
3.00
1.75
1..85
0.59
3.01
1.20
+
3.20
1.36
4.85
2.00
+ +
3.37
1.39
4.75
1.73
+ + +
+ +
5.62
2.44
7.78
3.50
+ + +
+ +
6.05
2.90
0.23
0.08
0.24
0.08
0.26
0?09
0.24
0.08
0.48
0.26
+ +
0.50
0.27
0.61
0.30
+ + H
0.53
0.28
0.61
0.22
+ + +
n. s.
0.61
0.24
0.75
0.39
h + + +
n. s.
0.66
0.20
79
8
97
8
113
13
83
8
101
14
+ + -
118
14
141
16
+ + -
99
15
101
13
f + + +'
n. s.
119
14
142
15
h + + +
n. s.
105
15
pl Control vs. patients with fatty liver resp. alcoholic cirrhosis.
p2 Patients with fatty liver vs. patients with alcoholic liver cirrhosis
* p < 0.05, ** p < 0.01, *** p < 0.001.
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Fig. l. Concentrations of adrenaline, noradrenaline, dopa-
mine and heart rate referred to the respective resting
value, during increasing ergometric loading (0, 50, 100
watts, 10 min recovery) in 16 normal subjects, 16
patients with alcoholic fatty liver, and 14 patients with
alcoholic cirrhosis.
The data represent mean values and mean Standard
deviations; *, ** identify significant differences frorn
the control group, with p < 0.05 or p < 0.001, re-
spectively; a identifies significant differences between
patients with fatty liver and cirrhosis, with p < 0.05.
during ergometry. With the exception bf the fall in
heart rate in the recovery phase in patients with fatty
liver, the changes in the heart rate are identical in
all three groups. At 50 watts loading, patients with
alcoholic cirrhosis showed statistically significant in-
creases only in noradrenaline (p < 0.05), when com-
pared with controls. At 100 watts loading, both ad-
renaline and noradrenaline were increased (p < 0.01
each). Dopamine was increased (p < 0.05) in patients
with fatty liver.
If, instead of absolute figures, the percentage
deviations in catecholamine concentrations under
exercise vis-a-vis the respective resting concentrations
are compared, the differences between the 3 groups
investigated are found to be considerably less marked
and no longer statistically differentiable. Thus, for
example, under a load of 100 watts, the noradrenaline
concentrations increased by 54% ± 77% in the
normal subjects, and by 71% ± 63% and 65% +
46%, respectively, in patients with fatty liver and
alcoholic cirrhosis.
During stepwise ergometric loading, adrenaline and
noradrenaline show an almost parabolic increase in
relation to heart rate (fig. 2), the curve being steeper
in the case of the patients. The ratio of noradren line
to adrenaline at rest is 3.6 ± 1.3, 3.5 + 1.4 and 4.0
+ 1.2 for the control group, patients with fatty liver,
and those with alcoholic cirrhosis, the differences
being non-significant. The ratio, noradrenaline to
adrenaline, remains constant in each group
throughout increasing ergometric loading.
The amount of adrenaline and noradrenaline excreted
in both patient groups in relation to the serum con^
centrations is oiily moderately elevated in all groups
(fig. 3). Statistically, the three groups show no
differences in the mean amount of adrenaline and
•56
1.5
2 1
0.5
80 100 · 120
Heart rate [mirr1] UO
Fig. 2. Concentrations of horadren line and adrenaline during
increasing ergometry loading (0, 50, 100 watts) in
relationship to the heaft rate in 16 normal subjects (·),
16 patients with alcoholic fatty liver (x), and 14 patients
with alcoh.olic cirrhosis (A) (means + Standard devia-
tion).
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Fig. 3. Excretion of adrenaline, noradrenaline and van-
illylmandelic acid in the control group (n = 16), and
in patients with fatty liver (n = 12) or alcoholic cirrhosis
(n = 9). The data represent mean values with respective
Standard deviations. Significant differences between the
control group and the patients are found only for
vanillylmandelic acid excretion (* p < 0.002).
noradrenaline excreted, although the patients with
alcoholic cirrhosis do reveal a tendency towards
higher catecholamine elimination than to patients
with fatty liver, or controls. In contrast, the mean
excretion of vanillylmandelic acid in patients with
cirrhosis (l .87 ± 0.7 μπιοΐ/mmol creatinine) and also
in the patients with fatty liver (l .64 + 0.5 μπιοΐ/mmol
creatinine) is significantly reduced in comparison to
the controls (2.19 ± 0.5 μπιοΐ/mmol creatinine) (p
< 0.002 in each case). With respect to the excretion
of vanillylmandelic acid, no statistically significant
differences are found between the two groups of
patients.
Discussion
The present result show that resting plasma cat-
echolamine concentrations are already increased in
chfonic alc holics without advanced liver disease.
They further increase in §ubjects with alcohol-induced
liver cirrhosis. The latter finding is in accordance
with results obtained by other authors in patients
with advanced alcoholic pr n n-alcoholic cirrhosis
(9-11). In contrast to the increased catecholamine
concentrations in the alc holics with only mild signs
of liver disease, patients with non-alcoholic cirrhosis
with moderate portal hypertension and without
ascites had normal values (12).
The possible causes of this increase in concentration
of plasma catecholamines are manifold, for example,
an increase in synthesis, a reduction in re-uptake,
impaired metabolism or reduced clearance (9). Ac-
companying diseases or drugs can also influence these
mechanisms. Thus, it is wellknown that patients with
heart failure (13) or duodenal ulcers (14) have el-
evated levels of adrenaline in the plasma, while
diuretics have only little effect on plasma and urine
catecholamines (15). Patients with alcoholic liver dis-
ease and cardiac insufficiency or duodenal ulcers were
included in the investigations, since their cat-
echolamine concentrations did not differ from those
of the remaining patients (since they had no influence
on the results of the investigations). Although ex-
cretion in 24-hour urine in patients with alcoholic
liver disease does not differ significantly from that of
the control group, it does increase s liver damage
progresses. Thus, it is unlikely that impaired renal
clearance is the cause of the increase in concentration.
Indeed, s Burghardt et al. (9) and Henriksen et al.
(10, 11) were recently able to show, cirrhosis of the
liver with a wide r nge of aetiologies is associated
with an increase in renal secretion of noradrenaline.
These data show that elevated plasma catecholamine
concentrations do not always indicate Stimulation of
the sympathoadren l System s a whole. For this
reason, the plasma concentrations were measured not
only at rest, but also under exercise conditions. Here,
it was revealed that the catecholamine concentrations
increase under exercise conditions in proportion to
the basal concentrations. In relation to the initial
levels, the increases in catecholamine concentrations
are identical in all three groups. The heart rate also
behaves in a similar manner. In the patient groups
with higher resting values, the increase under exercise
conditions was greater than in the control group. But
increases in heart rate after infusion of cat-
echolamines are observed only when noradrenaline
concentrations are ten times higher, and adrenaline
concentrations four times higher than the respective
mean basal concentrations (16). Since such high cat-
echolamine concentrations were not observed in the
patients, the elevated catecholamine levels and heart
rates observed at rest and under exercise can probably
not be explained on the basis of an isolated renal and
adrenal secretion of catecholamines. Instead, it must
be assumed that in these patients the neuronal activity
of the sympathetic nervous System is also raised. In
consequence of an increase in transmitter secretion
in the synapses and, possibly, also of a reduction
in re-uptake into the adrenergic neurons, increased
amounts of noradrenaline enter the circulation. This
augmentation of increased activity of the
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sympathoadrenal System äs a whole is underscored by
the fact that the ratio of noradrenaline to adrenaline
concentration is the same at rest and during bicycle
ergometry, although the noradrenaline and ad-
renaline are from different sources.
An epidemiological study of more than 80000 people
revealed a significant increase in the average blood
pressure values äs a function of the mean alcohol
consumption (17). This increase in blood pressure
values was independent of age, sex, race or other
risk factors such äs cigarette smoking, adiposity and
coffee consumption. The augmented activity of the
sympathoadrenal System suspected on the basis of
the results of the present investigation, may be con-
sidered a leading cause of elevated blood pressure in
persons with a high alcohol consumption.
A striking observation is that, in comparison with
the greatly elevated plasma catecholamine con-
centrations, catecholamine excretion is only
moderately elevated, and that there is a significant
reductiön in the excretion of vanillylmandelic acid äs
compared with the control group. The latter finding
was also reported by Ogata et al. (4) in patients with
chronic alcohol abüse, and by Davis et al. (18) after
acute administration of alcohol·, a simultaneous in-
crease in 3-methoxy-4-hydroxyphenyl glycol also be-
ing observed. Other authors (2), however, found no
difference in the renal excretion of adrenaline and
noradrenaline in chronic alcoholics during absti-
nence. The possible cause of a change in the relation-
ship of vanillylmandelic acid to 3-methoxy^4-
hydroxyphenyl glycol in acute alcohol administration
may be the elevatiön in the hepatic NADH/NAD+
quotient due to catabolism of the alcohol. However,
this caiinot explain the results of the present in-
vestigation, since the patients were not acutely
exposed to alcohol.
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